As an industry leader in lipid delivery technology, Scindy Pharmaceutical leverages its deep understanding of lipid chemistry and proprietary advanced lipid material platform to achieve breakthrough applications of LNP technology. We proudly introduce the NeoLNP? series of innovative cell transfection products, marking a new era of precise and efficient RNA delivery by systematically applying LNP technology to in vitro transfection.

The NeoLNP? RNA Transfection Kit for Immune Cell Lines (SDR2006) serves as an accelerator for immune cell line research. Developed for commonly used immune cell lines, this product achieves >90% transfection efficiency in cell lines like Jurkat, THP-1, and DC2.4 through modular lipid library construction and formulation optimization. Its unique endogenous delivery mechanism ensures high transfection activity while elevating cell viability to industry-leading levels, providing standardized solutions for CRISPR editing and mRNA vaccine development.

NeoLNP? SDR2006: The Preferred Choice for Immune Cell Line RNA Transfection

mRNA Immune Cell Transfection - A New Transfection Experience

Jurkat Cell Line

* Using a 24-well plate, transfect with 1μg eGFP mRNA per well, followed by fluorescence imaging and flow cytometry analysis after 24 hours.

THP-1 Cell Line

* Using a 24-well plate, transfect with 500ng eGFP mRNA per well, followed by fluorescence imaging and flow cytometry analysis after 24 hours.

U266 Cell Line

* Using a 24-well plate, transfect with 500ng eGFP mRNA per well, followed by fluorescence imaging and flow cytometry analysis after 24 hours.

DC2.4 Cell Line

* Using a 24-well plate, transfect with 500ng eGFP mRNA per well, followed by fluorescence imaging and flow cytometry analysis after 24 hours.

siRNA Transfection - Superior Delivery Performance, Surpassing Industry Standards

* Transfect with 15pmol siRNA per well (24-well plate), followed by qPCR analysis after 48 hours to measure target gene mRNA level changes.